Investigating the Efficacy and Safety of Oroxylum Indicum Extract on Overweight and Obese Subjects: A Randomized Controlled Clinical Trial (A Pilot Study)

Not Applicable

• Conditions: Overweight, obesity; anti- hyperlipidemia effect

• Registration Number: TCTR20200520001
• Lead Sponsor: Suranaree University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-20
• Study Completion: 2020-09-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

The inclusion criteria: men and women 30 to 60 years of age, affected by overweight or obesity, with the body mass index (BMI) of 25â€35 kg/m2 and without a previous diagnosis of cardiovascular disease

Exclusion Criteria

(1) coronary heart diseases, e.g. heart failure, myocardial infarction, arrhythmia; (2) endocrine disease, e.g. sex gland disorder, thyroid disorder, and pituitary disorder; (3) pregnant or lactating women; (4) taking medications or supplements and herbals that might interfere with blood glucose and lipid measurements. Subjects were excluded if they had side effects from the extract.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
anti-hyperlipidemia effect 12 week (measure every month) Serum lipid (Cholesterol, Triglyceride, LDL-C and HDL-C) measurement

Secondary Outcome Measures

Name	Time	Method
anti-hyperglycemia effect 12 week (measure every month) oral glucose tolerance testing